Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Trending Now
AAVantgarde’s AAVB-039 gene therapy to treat Stargardt disease receives orphan drug status from FDA | Ophthalmology Times
Q&A: The ARCHER trial and the importance of continued GA research | Ophthalmology Times
Q&A: Frank Holz shares how innovation showcased at EURETINA brings hope for patients with GA | Ophthalmology Times
Breaking News
Surgical innovation in dry eye disease: Salivary gland transplant
Ağustos 27, 2025
Next-generation IOLs advance complex cataract care
Ağustos 26, 2025
OCT changes with low-level red light therapy for myopia in children
Ağustos 26, 2025
Alcon presenting at APACRS 2025
Ağustos 21, 2025
Breaking News
Popular Now
FDA grants breakthrough therapy designation to Nacuity’s NPI-001 for retinitis pigmentosa | Ophthalmology Times
(Image Credit: AdobeStock) The US Food and Drug Administration (FDA) has granted…
AAVantgarde’s AAVB-039 gene therapy to treat Stargardt disease receives orphan drug status from FDA | Ophthalmology Times
(Image Credit: AdobeStock/artacet) The US Food and Drug Administration (FDA) has granted…
Q&A: The ARCHER trial and the importance of continued GA research | Ophthalmology Times
(Image credit: AdobeStock/J Bettencourt) In conversation with Sydney M. Crago, Managing Editor…
Charles Miller, MD, PhD, on DME research and the initiation of the phase 2b/3 BRUNELLO trial | Ophthalmology Times
Image credit: AdobeStock/MrAshi On September 4, 2025, Merck and EyeBio announced that…
Collaborate With Us
Join forces with Ophthalmology News to reach a global community of eye care professionals. Whether you want to contribute an article, share research, or explore partnership opportunities, we’d love to hear from you.
Editor Choice
Avoiding disasters and oculofacial surgery – Ophthalmology Times
Avoiding disasters and oculofacial surgery Ophthalmology Times Source: Author: | Date: 2025-08-30 13:31:00…
Avoiding disasters and oculofacial surgery
(Image credit: AdobeStock/Georgii) Jeremiah Tao, MD, FACS, is a clinical professor of ophthalmology…
Regenerons $0.33 Billion Trading Day 287th in Activity as Sepsis Trial Advances and Eylea HD Approval Drive Mixed Investor Signals – AInvest
Regenerons $0.33 Billion Trading Day 287th in Activity as Sepsis Trial Advances…
NK Insights: An Interactive Corneal Sensitivity Testing Workshop – Ophthalmology Times
NK Insights: An Interactive Corneal Sensitivity Testing Workshop Ophthalmology Times Source: Author: |…
Navigating the dangers of oculofacial surgery – Ophthalmology Times Europe
Navigating the dangers of oculofacial surgery Ophthalmology Times Europe Source: Author: | Date:…
Ophthalmology Plans of Private Health Insurance Market to See Rapid Expansion | Humana, EyeBenefits – openPR.com
Ophthalmology Plans of Private Health Insurance Market to See Rapid Expansion |…
An artificial intelligence cloud platform for OCT-based retinal anomalies screening system in real clinical environments – Nature
An artificial intelligence cloud platform for OCT-based retinal anomalies screening system in…
An Interactive Corneal Sensitivity Testing Workshop
Thanks for your interest in this podcast. Please read this important program…
A study of the progression of sensitivity loss in GA over time using inferred data
(Image Credit: AdobeStock) The recent OMEGA study1 found that “inferred sensitivity” mapping…
Worth Reading
Meeting expectations with evolving technology
Ağustos 26, 2025
/ Patient Education, Research & Studies, Technology & Innovation, Treatments & Surgery
Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
Ağustos 26, 2025
/ Industry News, Patient Education, Research & Studies, Treatments & Surgery
Possible protective role of cannabis in preventing postoperative proliferative vitreoretinopathy after retinal detachment repair
Ağustos 26, 2025
/ Patient Education, Research & Studies
Next-generation IOLs advance complex cataract care
Ağustos 26, 2025
/ Patient Education, Research & Studies, Treatments & Surgery
Subscribe Now
Enter your email address below and subscribe to our newsletter